Company / Interest Expense per Share
Cocrystal Pharma, Inc. Interest Expense per Share History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2021
5-year range
-$0.09 / $0.00
FY2017-FY2021
Trend
-89.5%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.00 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2021.
Improved from $0.00 to $0.00 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, interest expense per share decreased 89.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $0.00 | -89.5% |
| FY2020 | $0.00 | -72.1% |
| FY2019 | $0.00 | +102.0% |
| FY2012 | -$0.09 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026